Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / NBIX - Neurocrine Biosciences Non-GAAP EPS of -$0.51 revenue of $420.4M beats by $11.33M


NBIX - Neurocrine Biosciences Non-GAAP EPS of -$0.51 revenue of $420.4M beats by $11.33M

2023-05-03 07:42:54 ET

  • Neurocrine Biosciences press release ( NASDAQ: NBIX ): Q1 Non-GAAP EPS of -$0.51.
  • Revenue of $420.4M (+35.4% Y/Y) beats by $11.33M .
  • First Quarter INGREZZA Net Product Sales Highlights:

    • INGREZZA first quarter 2023 net product sales were $410 million and grew 36% compared vs. the first quarter 2022
    • Record number of new patients received therapy during the first quarter of 2023

For further details see:

Neurocrine Biosciences Non-GAAP EPS of -$0.51, revenue of $420.4M beats by $11.33M
Stock Information

Company Name: Neurocrine Biosciences Inc.
Stock Symbol: NBIX
Market: NASDAQ
Website: neurocrine.com

Menu

NBIX NBIX Quote NBIX Short NBIX News NBIX Articles NBIX Message Board
Get NBIX Alerts

News, Short Squeeze, Breakout and More Instantly...